Program Director, UNILAG
Oluwatoyin Amira, MB.BS (Ib), M.Sc (Wits), FWACP, ISN Fellow, is a Professor of Medicine at the College of Medicine, University of Lagos & a Consultant Nephrologist at the Lagos University Teaching Hospital (LUTH) Idi-Araba. She has over twenty years of clinical, teaching, and research experience in Internal Medicine, Hypertension, and Nephrology.
Her area of research interest includes chronic kidney disease (CKD) prevention and treatment, HIV nephropathy, and cardiovascular diseases among CKD patients. Her current research is on the role of apolipoprotein L1 (APOL1) gene variants as risk factors for the development of CKD and Lupus Nephritis among Nigerians. She is at present the LUTH Clinical Site Principal Investigator for the H3 Africa Kidney Disease Cohort Study, Sickle Cell Nephropathy Study and Diet, and APOL-1 study. These multi-center studies aim at elucidating the gene-environment interactions and mechanisms of ApoL1 in the development and progression of CKD. As part of the CKD prevention project, she set up the first community-based screening program for CKD risk factors in Southwest Nigeria, from 2005 to 2009 and contributed to the development of Guidelines for the detection and management of chronic kidney disease in Nigeria.
Prof. Amira is actively involved in training and mentoring of both undergraduate and postgraduate students in Medicine and other allied health care workers and serves as an examiner to several universities and the West African College of Physicians. She is currently the Chairperson of the Research & Ethics Committee of the African Nephrology Association and Director for the Emory- Nigerian Research Training Program.